NEWSMAX @NEWSMAX
U.S. drugmaker Pfizer and its German partner BioNTech have started an early-stage study to evaluate a combination vaccine targeting COVID-19 and influenza, the companies said on Thursday.https://t.co/HcMApTiacD — PolitiTweet.org
Created
Thu Nov 03 13:50:00 +0000 2022
Likes
63
Retweets
22
Source
Emplifi
View Raw Data
JSON DataView on Twitter
Likely Available
NEWSMAX @NEWSMAX
U.S. drugmaker Pfizer and its German partner BioNTech have started an early-stage study to evaluate a combination vaccine targeting COVID-19 and influenza, the companies said on Thursday.https://t.co/HcMApTiacD — PolitiTweet.org